Mercaptopurine

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

Pharma Deals, Investments and M&As in September 2017

In our continuous endeavor to share business intelligence that can help grow your pharmaceutical bus

FDA reorganizes inspection staff; Thermo Fisher buys Patheon for $ 5.2 billion

This week in Phispers, read about the extortion cyberattack and how it impacted hospitals in the UK.

Price gouging by Aspen in Italy; explosion at BASF; India acts on illegal Metformin exports

This week, Phispers gets you news on illegal exports of Metformin in India, Hillary Clinton’s